Crystal structure of SARS-CoV-2 main protease E166V mutant in complex with an inhibitor TKB-272
Coordinates
PDB Format
Method
X-RAY DIFFRACTION
2.07 Å
Oligo State
homo-dimer
Ligands
2 x
WOK:
(1R,2S,5S)-N-{(1S,2S)-1-(5-fluoro-1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide(Covalent)
Higashi-Kuwata, N. et al., TKB272, an Orally Available SARS-CoV-2-Mpro Inhibitor Containing 5-Fluorobenzothiazole, Potently Blocks SARS-CoV-2 Replication without Ritonavir. To Be Published